Megaphone Eyewire headlines are now available as a weekly podcast! Listen Now

Now Playing

Eyewire TV June 15, 2022 thumbnail

Introduction

story 1 thumbnail

Lensar Receives FDA Clearance for the ALLY Adaptive Cataract Treatment System

story 2 thumbnail

Aldeyra Achieves Primary Endpoint in Phase 3 Trial of Dry Eye Disease Drug Candidate Reproxalap

story 3 thumbnail

NIH Study Confirms Benefit of AREDS2 Formula for Slowing AMD


Previous EyewireTV Episodes